where U represents the formula (A) or (B) where V represents hydrogen or halogen atom, (C1-C3)-alkyl group or one either two (C1-C3)-alkoxy-groups; each of W and X represents two oxygen atoms either oxygen atom and group CH2 or group CH2 and oxygen atom, either oxygen atom and group CO; n = 0 or 1; R represents propyl group when U means the formula (A) either hydrogen atom or (C1-C3)-alkyl when U means the formula (B); Y represents one or more atoms or group including hydrogen, halogen atom and so on; Z represents hydrogen, oxygen atom. Invention relates also to drug containing compound of the formula (I) showing affinity to dopaminergic receptors of type D2 and D3 and serotoninergic receptors of type 5-HT1A and 5-HT2 and to pharmaceutical composition showing affinity to dopaminergic receptors of type D2 and D3 and serotoninergic receptors of type 5-HT1A and 5-HT2 containing compound of the formula (I) and excipient. Invention provides synthesis of novel derivatives of 8-azabicyclo[3.2.1]octane- -3-methanamine. EFFECT: valuable medicinal and pharmacological properties of compounds. 6 cl, 3 tbl"/>
DERIVATIVES OF 8-AZABICYCLO3,2,1OCTANE-3-METHAN- AMINE AS LIGANDS OF DOPAMINE RECEPTORS D2 AND D3 AND SEROTONIN RECEPTORS 5-HT1A AND 5-HT2 AND DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
首页>
外国专利>
DERIVATIVES OF 8-AZABICYCLO3,2,1OCTANE-3-METHAN- AMINE AS LIGANDS OF DOPAMINE RECEPTORS D2 AND D3 AND SEROTONIN RECEPTORS 5-HT1A AND 5-HT2 AND DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
DERIVATIVES OF 8-AZABICYCLO3,2,1OCTANE-3-METHAN- AMINE AS LIGANDS OF DOPAMINE RECEPTORS D2 AND D3 AND SEROTONIN RECEPTORS 5-HT1A AND 5-HT2 AND DRUG AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF
FIELD: organic chemistry, medicine, pharmacology. SUBSTANCE: invention relates to novel derivatives of 8-azabicyclo[3.2.1]octane-3- -methanamine as pure geometrical -isomers of the general formula (I) where U represents the formula (A) or (B) where V represents hydrogen or halogen atom, (C1-C3)-alkyl group or one either two (C1-C3)-alkoxy-groups; each of W and X represents two oxygen atoms either oxygen atom and group CH2 or group CH2 and oxygen atom, either oxygen atom and group CO; n = 0 or 1; R represents propyl group when U means the formula (A) either hydrogen atom or (C1-C3)-alkyl when U means the formula (B); Y represents one or more atoms or group including hydrogen, halogen atom and so on; Z represents hydrogen, oxygen atom. Invention relates also to drug containing compound of the formula (I) showing affinity to dopaminergic receptors of type D2 and D3 and serotoninergic receptors of type 5-HT1A and 5-HT2 and to pharmaceutical composition showing affinity to dopaminergic receptors of type D2 and D3 and serotoninergic receptors of type 5-HT1A and 5-HT2 containing compound of the formula (I) and excipient. Invention provides synthesis of novel derivatives of 8-azabicyclo[3.2.1]octane- -3-methanamine. EFFECT: valuable medicinal and pharmacological properties of compounds. 6 cl, 3 tbl
展开▼